======= GATA5 ======= == Gene Information == * **Official Symbol**: GATA5 * **Official Name**: GATA binding protein 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=140628|140628]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BWX5|Q9BWX5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GATA5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GATA5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611496|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a transcription factor that contains two GATA-type zinc fingers. The encoded protein is known to bind to hepatocyte nuclear factor-1alpha (HNF-1alpha), and this interaction is essential for cooperative activation of the intestinal lactase-phlorizin hydrolase promoter. In other organisms, similar proteins may be involved in the establishment of cardiac smooth muscle cell diversity. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Transcription factor required during cardiovascular development (PubMed:23289003). Plays an important role in the transcriptional program(s) that underlies smooth muscle cell diversity (By similarity). Binds to the functionally important CEF-1 nuclear protein binding site in the cardiac-specific slow/cardiac troponin C transcriptional enhancer (PubMed:25543888). {ECO:0000250|UniProtKB:P97489, ECO:0000269|PubMed:23289003, ECO:0000269|PubMed:25543888}. |GATA| |GATA-N| |regulation of cardiac endothelial to mesenchymal transition| |positive regulation of cardiac endothelial to mesenchymal transition| |regulation of Notch signaling pathway involved in heart induction| |endocardial cushion fusion| |positive regulation of Notch signaling pathway involved in heart induction| |positive regulation of transcription from RNA polymerase II promoter involved in heart development| |positive regulation of heart induction| |cell adhesion involved in heart morphogenesis| |regulation of heart induction| |regulation of transcription from RNA polymerase II promoter involved in heart development| |intestinal epithelial cell differentiation| |enhancer sequence-specific DNA binding| |negative regulation of cardiac muscle hypertrophy| |aortic valve morphogenesis| |negative regulation of muscle hypertrophy| |aortic valve development| |endocardial cushion morphogenesis| |regulation of animal organ formation| |semi-lunar valve development| |regulation of heart morphogenesis| |endocardial cushion development| |mesenchyme morphogenesis| |positive regulation of Notch signaling pathway| |heart valve morphogenesis| |regulation of cardiac muscle hypertrophy| |regulation of muscle hypertrophy| |heart valve development| |positive regulation of animal organ morphogenesis| |regulation of muscle adaptation| |columnar/cuboidal epithelial cell differentiation| |regulation of Notch signaling pathway| |cellular response to BMP stimulus| |response to BMP| |digestive tract development| |digestive system development| |cardiac muscle tissue development| |transcription regulatory region DNA binding| |mesenchyme development| |regulation of muscle system process| |nuclear chromatin| |heart morphogenesis| |regulation of animal organ morphogenesis| |cell-cell adhesion via plasma-membrane adhesion molecules| |striated muscle tissue development| |blood coagulation| |coagulation| |muscle tissue development| |hemostasis| |wound healing| |regulation of body fluid levels| |cellular response to growth factor stimulus| |RNA polymerase II proximal promoter sequence-specific DNA binding| |cell-cell adhesion| |heart development| |response to growth factor| |tissue morphogenesis| |response to wounding| |regulation of system process| |DNA-binding transcription factor activity| |epithelial cell differentiation| |zinc ion binding| |tube development| |circulatory system development| |cell adhesion| |biological adhesion| |animal organ morphogenesis| |positive regulation of cell differentiation| |regulation of anatomical structure morphogenesis| |epithelium development| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |positive regulation of developmental process| |response to endogenous stimulus| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of signal transduction| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|1.78| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7074 * **Expression level (log2 read counts)**: -5.6 {{:chemogenomics:nalm6 dist.png?nolink |}}